| St Lukes Hospice Duluth 220 North Sixth Avenue East, Duluth, MN, 55805 | |
| (218) 249-6111 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
Researchers have conducted a mathematical modeling study to understand how expanding vaccination to younger age groups may reduce the increasing case numbers.
Vaccinating infants against rotavirus, a leading cause of severe diarrhea and dehydration among babies and young children, was associated with a dramatic decline in U.S. hospitalization rates for acute gastroenteritis.
A team of researchers led by a member of the Colorado School of Public Health faculty at the Anschutz Medical Campus examined what type of social interaction is required for people to display physiological synchrony-mutual changes in autonomic nervous system activity.
› Verified 6 days ago
| Name | St Lukes Hospice Duluth |
|---|---|
| Location | 220 North Sixth Avenue East, Duluth, Minnesota |
| Hospice ID | 241524 |
| Category | Part of a hospital |
| Ownership Type | Voluntary Non-profit - Private |
| Profit Type | NON-PROFIT |
| Accreditation Provider | The Joint Commission (TJC) |
| SSA county code | 680 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
Researchers have conducted a mathematical modeling study to understand how expanding vaccination to younger age groups may reduce the increasing case numbers.
Vaccinating infants against rotavirus, a leading cause of severe diarrhea and dehydration among babies and young children, was associated with a dramatic decline in U.S. hospitalization rates for acute gastroenteritis.
A team of researchers led by a member of the Colorado School of Public Health faculty at the Anschutz Medical Campus examined what type of social interaction is required for people to display physiological synchrony-mutual changes in autonomic nervous system activity.
› Verified 6 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.8 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 97.5 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 89.2 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 52.1 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 95.5 | 97.3 |
| Patients who got timely treatment for shortness of breath | 97.3 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 96.0 | 93.3 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
Researchers have conducted a mathematical modeling study to understand how expanding vaccination to younger age groups may reduce the increasing case numbers.
Vaccinating infants against rotavirus, a leading cause of severe diarrhea and dehydration among babies and young children, was associated with a dramatic decline in U.S. hospitalization rates for acute gastroenteritis.
A team of researchers led by a member of the Colorado School of Public Health faculty at the Anschutz Medical Campus examined what type of social interaction is required for people to display physiological synchrony-mutual changes in autonomic nervous system activity.
› Verified 6 days ago
| Home Health Aides | 1.8 |
| Counselors | 1 |
| Homemakers | 0.05 |
| Medical Social Workers | 1.5 |
| Physicians | 0.2 |
| Registered Nurses | 6.6 |
| Other Personnel | 4.6 |
| Total Employees | 15.75 |
|---|
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
Researchers have conducted a mathematical modeling study to understand how expanding vaccination to younger age groups may reduce the increasing case numbers.
Vaccinating infants against rotavirus, a leading cause of severe diarrhea and dehydration among babies and young children, was associated with a dramatic decline in U.S. hospitalization rates for acute gastroenteritis.
A team of researchers led by a member of the Colorado School of Public Health faculty at the Anschutz Medical Campus examined what type of social interaction is required for people to display physiological synchrony-mutual changes in autonomic nervous system activity.
› Verified 6 days ago
| Essentia Health St Marys Hospice & Palliative Care Location: 330 East 2nd Street, Duluth, Minnesota, 55805 Phone: (218) 249-6111 |
| St Lukes Hospice Duluth Location: 220 North Sixth Avenue East, Duluth, Minnesota, 55805 Phone: (218) 249-6111 |